Skip to content

Impact of antibiotic resistance

Epidemiology and clinical outcome of common multi drug resistant gram negative bacterial infection in a network of hospitals in India (IMPRES): a multicenter, Intensive care unit-based, prospective clinical study. - IMPRES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/049121
Enrollment
500
Registered
2023-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B962- Escherichia coli [E. coli ] as thecause of diseases classified elsewhere Health Condition 2: B961- Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere Health Condition 3: B99- Other and unspecified infectious diseases Health Condition 4: B965- Pseudomonas (aeruginosa) (mallei)(pseudomallei) as the cause of diseases classified elsewhere Health Condition 5: B955- Unspecified streptococcus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Indian Society of Critical Care Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are admitted in ICU Patients who are clinically diagnosed to have infection Patients who have positive report of identification of one these organism: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. (PEAK organism)

Exclusion criteria

Exclusion criteria: Patient who are not treated with curative intent Patient who are previously enrolled in the study

Design outcomes

Primary

MeasureTime frame
mortality of patients who have confirmed infection with “PEAK ? organismTimepoint: 28 days from day of icu admission

Secondary

MeasureTime frame
Length of ICU stay, Need of organ support, Total ventilator days, Various pathogen and their resistance pattern.Timepoint: 28 days from the date of admission

Countries

India

Contacts

Public ContactSaurabh Kumar Das

Max Superspeciality Hospital, Shalimarbagh

dassk1729@gmail.com8587889525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026